GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indiva Ltd (TSXV:NDVA) » Definitions » YoY EBITDA Growth

Indiva (TSXV:NDVA) YoY EBITDA Growth : 50.00% (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Indiva YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Indiva's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 50.00%.

Indiva's EBITDA per Share for the three months ended in Mar. 2024 was C$-0.00.

Indiva YoY EBITDA Growth Historical Data

The historical data trend for Indiva's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indiva YoY EBITDA Growth Chart

Indiva Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.96 -12.40 33.82 48.89 104.35

Indiva Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.85 125.00 128.57 115.38 50.00

Indiva YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Indiva's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.002--0.046)/ | -0.046 |
=104.35 %

Indiva's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.003--0.006)/ | -0.006 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indiva YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Indiva's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Indiva (TSXV:NDVA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indiva Ltd (TSXV:NDVA) » Definitions » YoY EBITDA Growth
Comparable Companies
XCNQ:IMCC TSXV:MPH TSXV:HASH XCNQ:BAMM TSXV:CANB XCNQ:XTRX TSX:WLLW NEOE:FH TSXV:DHB TSX:VPH XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
NDVAF:USA T8RP:Germany
Address
333 Preston Street, Suite 710, Ottawa, ON, CAN, K1S 1N4
Website
https://www.indiva.com
Indiva Ltd sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, the company produces and distributes award-winning cannabis products nationally, including Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Sapphire Cannabis Salt, as well as capsules, pre-rolls and premium flower under the INDIVA and Artisan Batch brands.
Executives
Tweed Inc. 10% Security Holder

Indiva (TSXV:NDVA) Headlines

No Headlines